Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

earing Thursday in Warren's 37th District Court that was adjourned into next year at the request of his attorney." Bahri's court appointed attorney, Randy Rodnick, "sought the adjournment to obtain copies of investigative reports, videos and other materials that police allege link Bahri to the slayings." Rodn

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

earing Thursday in Warren's 37th District Court that was adjourned into next year at the request of his attorney." Bahri's court appointed attorney, Randy Rodnick, "sought the adjournment to obtain copies of investigative reports, videos and other materials that police allege link Bahri to the slayings." Rodn

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

earing Thursday in Warren's 37th District Court that was adjourned into next year at the request of his attorney." Bahri's court appointed attorney, Randy Rodnick, "sought the adjournment to obtain copies of investigative reports, videos and other materials that police allege link Bahri to the slayings." Rodn